FCE News
https://fcenews.it/index.php 2016-06-21T22:42:12Z Joomla! 1.5 - Open Source Content Management
Could restoring electrical signals help heal diabetic wounds
2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211402:could-restoring-electrical-signals&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected]Mouse study finds cornea wounds in diabetes have abnormal electric signals and suggests they could be a target in managing slow and non-healing wounds. ... ...
Mouse study finds cornea wounds in diabetes have abnormal electric signals and suggests they could be a target in managing slow and non-healing wounds. ... ...
Possible psoriasis drug target identified by Stanford researchers
2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211403:possible-psoriasis-drug-target&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected]Psoriasis is one of the most common human skin diseases. People with severe cases sometimes resort to immunosuppressive treatment to quell the skin scaling, itching and joint arthritis that are... ... ...
Psoriasis is one of the most common human skin diseases. People with severe cases sometimes resort to immunosuppressive treatment to quell the skin scaling, itching and joint arthritis that are... ... ...
New drug clears psoriasis in clinical trials
2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211404:drug-clears-psoriasis-clinical&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected]About 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term... ... ...
About 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term... ... ...
Lignin from plants boosts the effectiveness of sunscreen
2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211405:lignin-from-plants-boosts&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected]Warm weather means beach vacations and pool-dipping for many of us. It also signals a season of slathering on sunscreen to avoid getting burned. ... ...
Warm weather means beach vacations and pool-dipping for many of us. It also signals a season of slathering on sunscreen to avoid getting burned. ... ...
Stem cells from umbilical cord blood may help treat eczema
2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211406:stem-cells-from-umbilical&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected]A new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis. ... ...
A new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis. ... ...
Early detection, smaller cancer among benefits of skin cancer screening at primary care visits
2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211407:early-detection-smaller-cancer&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected]Skin cancer screenings performed by primary care physicians (PCPs) during routine office visits improve the detection of potentially deadly melanomas and find them in earlier stages, according to... ... ...
Skin cancer screenings performed by primary care physicians (PCPs) during routine office visits improve the detection of potentially deadly melanomas and find them in earlier stages, according to... ... ...
Investigational immunotherapy drug well tolerated in those with rare form of melanoma
2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211408:investigational-immunotherapy-drug-well&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected]An investigational immunotherapy drug being tested in the treatment of a rare form of skin cancer known as Merkel cell carcinoma has been found to be well tolerated with a clinical benefit seen in... ... ...
An investigational immunotherapy drug being tested in the treatment of a rare form of skin cancer known as Merkel cell carcinoma has been found to be well tolerated with a clinical benefit seen in... ... ...
Confocal microscopy effective in analyzing infestation of mites in human skin disease
2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211409:confocal-microscopy-effective-analyzing&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected]In the diagnosis of skin conditions caused by parasitic mites, a recent research study has outlined distinct advantages in the use of confocal microscope over the usual light microscope. ... ...
In the diagnosis of skin conditions caused by parasitic mites, a recent research study has outlined distinct advantages in the use of confocal microscope over the usual light microscope. ... ...
Atopic dermatitis: Positive topline Phase 3 results announced for dupilumab
2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211410:atopic-dermatitis-positive-topline&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected]Regeneron Pharmaceuticals, Inc. and Sanofi have announced that a one-year Phase 3 study, known as LIBERTY AD CHRONOS, evaluating investigational dupilumab met its primary and key secondary... ... ...
Regeneron Pharmaceuticals, Inc. and Sanofi have announced that a one-year Phase 3 study, known as LIBERTY AD CHRONOS, evaluating investigational dupilumab met its primary and key secondary... ... ...
Nanoparticle sunscreens effective and safe to use
2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211411:nanoparticle-sunscreens-effective-safe&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected]There has been public concern about the safety of nanoparticle sunscreens, but the available evidence indicates that they are both effective and safe to use, according to a Perspective published in... ... ...
There has been public concern about the safety of nanoparticle sunscreens, but the available evidence indicates that they are both effective and safe to use, according to a Perspective published in... ... ...